AU8121187A – Synthetic antigen for detection of aids-related disease
– Google Patents
AU8121187A – Synthetic antigen for detection of aids-related disease
– Google Patents
Synthetic antigen for detection of aids-related disease
Info
Publication number
AU8121187A
AU8121187A
AU81211/87A
AU8121187A
AU8121187A
AU 8121187 A
AU8121187 A
AU 8121187A
AU 81211/87 A
AU81211/87 A
AU 81211/87A
AU 8121187 A
AU8121187 A
AU 8121187A
AU 8121187 A
AU8121187 A
AU 8121187A
Authority
AU
Australia
Prior art keywords
aids
detection
related disease
synthetic antigen
polypeptides
Prior art date
1986-11-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU81211/87A
Other versions
AU616383B2
(en
Inventor
Wesley L. Cosand
Linda J. Harris
Ray. L. Houghton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Systems Corp
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1986-11-14
Filing date
1987-11-13
Publication date
1988-05-19
1987-11-13
Application filed by Genetic Systems Corp
filed
Critical
Genetic Systems Corp
1988-05-19
Publication of AU8121187A
publication
Critical
patent/AU8121187A/en
1991-10-31
Application granted
granted
Critical
1991-10-31
Publication of AU616383B2
publication
Critical
patent/AU616383B2/en
2007-11-13
Anticipated expiration
legal-status
Critical
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07K—PEPTIDES
C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
G—PHYSICS
G01—MEASURING; TESTING
G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 – G01N31/00
G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
G01N33/56983—Viruses
G01N33/56988—HIV or HTLV
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
C—CHEMISTRY; METALLURGY
C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
C12N2740/00—Reverse transcribing RNA viruses
C12N2740/00011—Details
C12N2740/10011—Retroviridae
C12N2740/16011—Human Immunodeficiency Virus, HIV
C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S435/00—Chemistry: molecular biology and microbiology
Y10S435/974—Aids related test
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
Y10S530/82—Proteins from microorganisms
Y10S530/826—Viruses
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y10S930/00—Peptide or protein sequence
Y10S930/01—Peptide or protein sequence
Y10S930/22—Viral peptide or viral protein
Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related
Abstract
Novel peptides are provided having substantially the same sequence as immunologically significant fragments of AIDS-related viruses. The polypeptides can be used as reagents in the determination of exposure of a human host to the virus. Of particular interest is the use of polypeptides in screening blood products.
AU81211/87A
1986-11-14
1987-11-13
Synthetic antigen for detection of aids-related disease
Expired
AU616383B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US930785
1986-11-14
US06/930,785
US5075211A
(en)
1986-03-26
1986-11-14
Synthetic antigen for the detection of AIDS-related disease
Publications (2)
Publication Number
Publication Date
AU8121187A
true
AU8121187A
(en)
1988-05-19
AU616383B2
AU616383B2
(en)
1991-10-31
Family
ID=25459766
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU81211/87A
Expired
AU616383B2
(en)
1986-11-14
1987-11-13
Synthetic antigen for detection of aids-related disease
Country Status (11)
Country
Link
US
(1)
US5075211A
(en)
EP
(1)
EP0267802B1
(en)
JP
(1)
JP2886861B2
(en)
AT
(1)
ATE163766T1
(en)
AU
(1)
AU616383B2
(en)
CA
(1)
CA1340097C
(en)
DE
(1)
DE3752170T2
(en)
DK
(1)
DK174533B1
(en)
ES
(1)
ES2115584T3
(en)
IE
(1)
IE81132B1
(en)
NO
(1)
NO173958C
(en)
Families Citing this family (23)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US7273695B1
(en)
*
1984-10-31
2007-09-25
Novartis Vaccines And Diagnostics, Inc.
HIV immunoassays using synthetic envelope polypeptides
US6210873B1
(en)
1987-08-28
2001-04-03
Board Of Regents, The University Of Texas System
Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A
(en)
*
1987-08-28
1992-07-07
Board Of Regents, The University Of Texas System
Prophylaxis and therapy of acquired immunodeficiency syndrome
FR2632310B1
(en)
*
1988-06-06
1992-04-10
Pasteur Institut
PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS
ZA896768B
(en)
*
1988-09-09
1990-06-27
Akzo Nv
Synthetic polypeptides immunochemically reactive with hiv-antibodies
US5439792A
(en)
*
1989-06-02
1995-08-08
Genetic Systems Corporation
Cysteine thiol-protected peptides for use in immunoassays
EP0731174B1
(en)
*
1989-07-11
2004-11-17
Gen-Probe Incorporated
Nucleic acid sequence amplification methods
US6589734B1
(en)
1989-07-11
2003-07-08
Gen-Probe Incorporated
Detection of HIV
US5627035A
(en)
*
1990-08-22
1997-05-06
Syntello Vaccine Development Ab
Peptides that block human immunodeficiency virus and methods of use thereof
SE9101863D0
(en)
*
1991-06-13
1991-06-13
Replico Medical Ab
PEPTIDES, DIAGNOSTIC ANTIGEN, VACCINE COMPOSITION AND PROCEDURES FOR SELECTING HIV STARMS
WO1993009252A1
(en)
*
1991-11-04
1993-05-13
Baxter Diagnostics Inc.
Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
ATE179716T1
(en)
*
1992-03-06
1999-05-15
Innogenetics Nv
METHOD FOR DETERMINING PEPTIDES ASSOCIATED WITH IMMUNOLOGICALLY IMPORTANT EPITOPES OF HCV
US6667387B1
(en)
*
1996-09-30
2003-12-23
N.V. Innogenetics S.A.
HCV core peptides
US6709828B1
(en)
1992-03-06
2004-03-23
N.V. Innogenetics S.A.
Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6632613B1
(en)
*
1993-06-02
2003-10-14
University Of Utah Research Foundation
Compositions and kits for fluorescence polarization assay of large molecules
US6479055B1
(en)
*
1993-06-07
2002-11-12
Trimeris, Inc.
Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5603933A
(en)
*
1993-08-31
1997-02-18
Board Of Regents, The University Of Texas
CD4 peptides for binding to viral envelope proteins
EP0733063B1
(en)
*
1993-12-09
2003-12-17
University of Utah Research Foundation
Compositions and kits for fluorescence polarization assay of large molecules
AU753780B2
(en)
*
1997-08-01
2002-10-31
Bio-Rad Laboratories, Inc.
Synthetic antigen for the detection of antibodies immunoreactive with HIV virus
GB9717652D0
(en)
*
1997-08-20
1997-10-22
Nycomed Imaging As
Method
WO2000029008A2
(en)
1998-11-16
2000-05-25
Board Of Regents, The University Of Texas System
Hiv-specific t-cell induction
EP1187939B9
(en)
*
1999-07-09
2009-08-12
Gen-Probe Incorporated
Detection of hiv-1 by nucleic acid amplification
US6582920B2
(en)
*
2000-09-01
2003-06-24
Gen-Probe Incorporated
Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
Family Cites Families (16)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
NZ207394A
(en)
*
1983-03-08
1987-03-06
Commw Serum Lab Commission
Detecting or determining sequence of amino acids
GB8324800D0
(en)
*
1983-09-15
1983-10-19
Pasteur Institut
Antigens
US4716102A
(en)
*
1984-08-15
1987-12-29
Regents Of The University Of California
Purified AIDS-associated virus ARV-2
US9328391B1
(en)
*
1984-08-22
2016-05-03
The United States Of America As Represented By The Secretary, Department Of Health And Human Services
Cloning and expression of HIV-1 DNA
ATE92502T1
(en)
*
1984-10-18
1993-08-15
Pasteur Institut
ENVELOPE ANTIGENS OF HUMAN IMMUNODEFICIENCY VIRUS AND THEIR USES.
CA1341482C
(en)
*
1984-10-31
2005-05-10
Paul A. Luciw
Process for preparing fragments of aids-associated retroviruses
JPS61233700A
(en)
*
1984-12-24
1986-10-17
ジエネンテク，インコ−ポレイテツド
Molecularly cloned aids related polypeptide
DE3650011T2
(en)
*
1985-04-08
1994-11-17
Genetic Systems Corp
EXPRESSION AND DIAGNOSIS WITH GAG-CODED PEPTIDES THAT ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES AGAINST LAV.
US4629783A
(en)
*
1985-04-29
1986-12-16
Genetic Systems Corporation
Synthetic antigen for the detection of AIDS-related disease
KR910002374B1
(en)
*
1985-04-29
1991-04-20
제네틱 시스템즈 코포레이션
Synthetic antigens for the detection of aids-relate disease
US4661445A
(en)
*
1985-05-24
1987-04-28
Saxinger W Carl
Competitive ELISA for the detection of HTLV-III antibodies
US4704357A
(en)
*
1985-09-30
1987-11-03
United States Of America As Represented By The Department Of Health And Human Services
Immortalized T-lymphocyte cell line for testing HTLV-III inactivation
CS256960B1
(en)
*
1985-11-16
1988-04-15
Viktor Krchnak
Peptides with properties of antigenic determinants and method of their production
AU6713287A
(en)
*
1986-01-06
1987-07-09
F. Hoffmann-La Roche & Co.
Expression of htlv-iii gag-gene
US4734362A
(en)
*
1986-02-03
1988-03-29
Cambridge Bioscience Corporation
Process for purifying recombinant proteins, and products thereof
WO1987007296A1
(en)
*
1986-05-20
1987-12-03
The Trustees Of Columbia University In The City Of
Expression of human t-cell lymphotropic virus (htlv-iii) reverse transcriptase and uses thereof
1986
1986-11-14
US
US06/930,785
patent/US5075211A/en
not_active
Expired – Lifetime
1987
1987-11-13
AT
AT87310047T
patent/ATE163766T1/en
not_active
IP Right Cessation
1987-11-13
IE
IE307387A
patent/IE81132B1/en
not_active
IP Right Cessation
1987-11-13
NO
NO874740A
patent/NO173958C/en
not_active
IP Right Cessation
1987-11-13
AU
AU81211/87A
patent/AU616383B2/en
not_active
Expired
1987-11-13
EP
EP87310047A
patent/EP0267802B1/en
not_active
Expired – Lifetime
1987-11-13
ES
ES87310047T
patent/ES2115584T3/en
not_active
Expired – Lifetime
1987-11-13
DK
DK198705977A
patent/DK174533B1/en
not_active
IP Right Cessation
1987-11-13
CA
CA000551770A
patent/CA1340097C/en
not_active
Expired – Lifetime
1987-11-13
DE
DE3752170T
patent/DE3752170T2/en
not_active
Expired – Lifetime
1987-11-13
JP
JP62287207A
patent/JP2886861B2/en
not_active
Expired – Lifetime
Also Published As
Publication number
Publication date
AU616383B2
(en)
1991-10-31
DE3752170T2
(en)
1998-10-08
ATE163766T1
(en)
1998-03-15
CA1340097C
(en)
1998-10-20
JPS63221247A
(en)
1988-09-14
DK597787A
(en)
1988-05-15
DK174533B1
(en)
2003-05-12
ES2115584T3
(en)
1998-07-01
EP0267802A2
(en)
1988-05-18
DE3752170D1
(en)
1998-04-09
NO874740L
(en)
1988-05-16
EP0267802A3
(en)
1991-03-06
JP2886861B2
(en)
1999-04-26
NO173958B
(en)
1993-11-15
NO874740D0
(en)
1987-11-13
US5075211A
(en)
1991-12-24
IE873073L
(en)
1988-05-14
NO173958C
(en)
1994-02-23
IE81132B1
(en)
2000-03-22
DK597787D0
(en)
1987-11-13
EP0267802B1
(en)
1998-03-04
Similar Documents
Publication
Publication Date
Title
ES8708058A1
(en)
1987-09-01
Synthetic antigen for the detection of aids-related disease
EP0220273A4
(en)
1989-10-04
Synthetic antigens for the detection of aids-related disease.
AU8121187A
(en)
1988-05-19
Synthetic antigen for detection of aids-related disease
AU8172094A
(en)
1995-03-23
Synthetic HTLV-III peptides, compositions and uses thereof
AU597698B2
(en)
1990-06-07
Expression products of human papilloma virus type 18, antibodies specific to these proteins, and diagnostic aids containing these antibodies or corresponding DNA
EP0284587A3
(en)
1990-11-22
Synthetic peptide antigens for the detection of hiv-1 infection
DE3872754D1
(en)
1992-08-20
DETECTION OF ANTIBODY HUMAN IMMUNDEFIZIENZ VIRUS.
ATE109830T1
(en)
1994-08-15
EXPRESSION OF VIRUS PROTEINS WITH IMMUNOLOGICAL ACTIVITY.
ES2080047T3
(en)
1996-02-01
HIV PEPTIDES AND METHODS FOR HIV DETECTION.
SE8902148L
(en)
1990-12-14
SYNTHETIC PEPTID ANTIGEN FOR DETECTION OF HTLV-1 INFECTION
EP1878805A3
(en)
2008-04-23
Synthetic antigen for the detection of antibodies immunoreactive with HIV virus
DK0671946T3
(en)
2000-11-13
Immune reactive peptides from Epstein-Barr virus
PT85220A
(en)
1987-07-01
Dna sequence recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides obtained products and preparations containing same
GB8915572D0
(en)
1989-08-23
Use of bluetongue virus proteins as vaccine components
IL83422A
(en)
1992-07-15
Method for the detection of human b lymphotropic virus antibodies
None